Trending
GE HealthCare (GEHC) gains 5.0% ahead of Q1 2026 earnings report
GE HealthCare (GEHC) shares are trading at $73.18, up 5.0% on 29 April 2026. The medical technology firm gained momentum ahead of its first-quarter 2026 earnings report, scheduled for today. The rise follows anticipation surrounding the upcoming Q1 2026 earnings. GE HealthCare h
Read story →
UnitedHealth Group (UNH) Shares Climb 8.0% on Medicare Advantage Payment News
UnitedHealth Group shares rose 8.0% today, trading at $303.885. The healthcare giant’s stock advanced from its previous close of $281.36. The surge followed t
Read story →
UnitedHealth Group (UNH) Shares Climb 8.5% on Medicare Advantage Payment Boost
UnitedHealth Group shares rose 8.5% to $305.36 on 25 October 2025, marking a significant intraday gain for the US healthcare giant. The move followed a larger-t
Read story →
CVS Health shares rise 4.9% after proposed FTC settlement for PBM business
CVS Health shares rose 4.9% to $76.86 on 7 April 2026, marking a significant intraday gain for the US healthcare giant. This movement follows a proposed settlem
Read story →
Lilly (Eli) Shares Gain 4.2% After Strong Earnings and 2026 Guidance
Lilly (Eli) shares rose 4.2% to $958.43 on 2026-04-01, building on earlier gains. The pharmaceutical giant’s current trading price compares with a previous clos
Read story →
Viatris Shares Gain 4.2% Following Investor Event Outlining Growth Strategy
Viatris shares are up 4.2% today, trading at $13.50. The pharmaceutical company's stock has risen from its previous close of $12.96. The upward movement follo
Read story →
Humana shares gain 4.8% after Medicare star ratings update
Humana shares are up 4.8% today, trading at $173.89. The move follows a rebound from recent lows around $166 on March 30. The rise is driven by the company's
Read story →
Boston Scientific shares fall 5.8% after earnings and clinical trial setback
Boston Scientific shares fell 5.8% to $65.175 on 4 February 2026, extending losses from a disappointing earnings report and a clinical trial setback. The medi
Read story →
Insulet Corporation (PODD) Shares Fall 4.5% to New 52-Week Low
Insulet Corporation shares fell 4.5% to $208.22 on 19 February 2026, marking a new 52-week low. The decline followed a series of analyst downgrades. JPMorgan l
Read story →
Diasorin (DIA) falls 12.8% after FTSE All-World Index rebalancing
Diasorin fell 12.8% to €55.62 on 24 March 2026. The Italian diagnostics company closed at €63.76 on the preceding trading day. The decline followed Diasorin's
Read story →